Site-directed Mutagenesis Service - Global 麻豆原创 Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Publication ID:

PB512248897

Publication Date:

December 9, 2024

Pages:

142

Publisher:

MRRPB5

Countries:

Global [1]

USD 3,950.00

IT Services [2]

Computing & Electronics [3]

Description:

The global market for Site-directed Mutagenesis Service was estimated to be worth US$ 974 million in 2023 and is forecast to a readjusted size of US$ 1353.3 million by 2030 with a CAGR of 4.8% during the forecast period 2024-2030
Site-directed mutagenesis is a widely used technique in molecular biology and genetic engineering that allows researchers to introduce specific changes or mutations into a DNA sequence.
Site-directed mutagenesis services are provided by various companies and research institutions to support scientific research, drug development, and other applications requiring precise modifications to DNA sequences. These services often involve the design and synthesis of custom DNA templates with specific mutations or modifications requested by the client.
The market status and future development trends of the site-directed mutagenesis service market include the following:
Increasing Demand: With advancements in genetic research and biotechnology applications, there is a growing demand for site-directed mutagenesis services. Researchers in academia, pharmaceutical companies, and biotech firms rely on these services to create specific genetic variants for functional studies, protein engineering, therapeutic development, and other research purposes.
Customization and Specialization: As the field of genetics becomes more specialized, site-directed mutagenesis service providers may focus on offering tailored solutions to meet the specific needs of different research areas or industries. This could involve expertise in specific organisms, gene families, or targeted genetic modifications.
Automation and High-throughput Capabilities: To improve efficiency and cost-effectiveness, site-directed mutagenesis services may adopt automation and high-throughput technologies. This allows for the simultaneous generation of multiple mutations or modifications in a faster and more streamlined manner.

Quality Assurance and Validation: Given the critical nature of site-directed mutagenesis in research and product development, there is an increasing emphasis on quality control, validation, and rigorous quality assurance measures by service providers. This ensures accurate and reliable results, which are essential for downstream applications.
Integration with Other Services: Site-directed mutagenesis services may be integrated with other molecular biology services or techniques to offer comprehensive solutions. For example, providers may offer sequencing, gene synthesis, or cloning services alongside site-directed mutagenesis to facilitate a seamless workflow for researchers.
Regulatory Compliance: As the applications of site-directed mutagenesis expand into areas like gene therapy or agricultural biotechnology, adherence to regulatory guidelines and ethical considerations will become increasingly important.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Site-directed Mutagenesis Service, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Site-directed Mutagenesis Service by region & country, by Type, and by Application.
The Site-directed Mutagenesis Service market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Site-directed Mutagenesis Service.
麻豆原创 Segmentation
By Company
GenScript
Eurofins
Applied Biological Materials
Azenta Life Sciences
Thermo Fisher Scientific
Bon Opus Biosciences
Charles Rive
Creative Biogene
Synbio Technologies
Creative Biolabs
NovoPro
Bionexus
Biotech Desk
NorClone
Eton Bioscience
Syd Labs
Genosphere Biotechnologies
WZ Biosciences
FulenGen
GENEWIZ
iGene Biotechnology
Tsingke
AtaGenix
Zoonbio Biotechnology
Segment by Type:
Standard Site-directed Mutagenesis Service
Customized Site-directed Mutagenesis Service
Segment by Application
Scientific Research
Gene Therapy
Cell Therapy
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Site-directed Mutagenesis Service manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Site-directed Mutagenesis Service in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Site-directed Mutagenesis Service in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 麻豆原创 Overview
1.1 Site-directed Mutagenesis Service Product Introduction
1.2 Global Site-directed Mutagenesis Service 麻豆原创 Size Forecast
1.3 Site-directed Mutagenesis Service 麻豆原创 Trends & Drivers
1.3.1 Site-directed Mutagenesis Service Industry Trends
1.3.2 Site-directed Mutagenesis Service 麻豆原创 Drivers & Opportunity
1.3.3 Site-directed Mutagenesis Service 麻豆原创 Challenges
1.3.4 Site-directed Mutagenesis Service 麻豆原创 Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Site-directed Mutagenesis Service Players Revenue Ranking (2023)
2.2 Global Site-directed Mutagenesis Service Revenue by Company (2019-2024)
2.3 Key Companies Site-directed Mutagenesis Service Manufacturing Base Distribution and Headquarters
2.4 Key Companies Site-directed Mutagenesis Service Product Offered
2.5 Key Companies Time to Begin Mass Production of Site-directed Mutagenesis Service
2.6 Site-directed Mutagenesis Service 麻豆原创 Competitive Analysis
2.6.1 Site-directed Mutagenesis Service 麻豆原创 Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Site-directed Mutagenesis Service Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Site-directed Mutagenesis Service as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Standard Site-directed Mutagenesis Service
3.1.2 Customized Site-directed Mutagenesis Service
3.2 Global Site-directed Mutagenesis Service Sales Value by Type
3.2.1 Global Site-directed Mutagenesis Service Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Site-directed Mutagenesis Service Sales Value, by Type (2019-2030)
3.2.3 Global Site-directed Mutagenesis Service Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Scientific Research
4.1.2 Gene Therapy
4.1.3 Cell Therapy
4.1.4 Others
4.2 Global Site-directed Mutagenesis Service Sales Value by Application
4.2.1 Global Site-directed Mutagenesis Service Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Site-directed Mutagenesis Service Sales Value, by Application (2019-2030)
4.2.3 Global Site-directed Mutagenesis Service Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Site-directed Mutagenesis Service Sales Value by Region
5.1.1 Global Site-directed Mutagenesis Service Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Site-directed Mutagenesis Service Sales Value by Region (2019-2024)
5.1.3 Global Site-directed Mutagenesis Service Sales Value by Region (2025-2030)
5.1.4 Global Site-directed Mutagenesis Service Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Site-directed Mutagenesis Service Sales Value, 2019-2030
5.2.2 North America Site-directed Mutagenesis Service Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Site-directed Mutagenesis Service Sales Value, 2019-2030
5.3.2 Europe Site-directed Mutagenesis Service Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Site-directed Mutagenesis Service Sales Value, 2019-2030
5.4.2 Asia Pacific Site-directed Mutagenesis Service Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Site-directed Mutagenesis Service Sales Value, 2019-2030
5.5.2 South America Site-directed Mutagenesis Service Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Site-directed Mutagenesis Service Sales Value, 2019-2030
5.6.2 Middle East & Africa Site-directed Mutagenesis Service Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Site-directed Mutagenesis Service Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Site-directed Mutagenesis Service Sales Value
6.3 United States
6.3.1 United States Site-directed Mutagenesis Service Sales Value, 2019-2030
6.3.2 United States Site-directed Mutagenesis Service Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Site-directed Mutagenesis Service Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Site-directed Mutagenesis Service Sales Value, 2019-2030
6.4.2 Europe Site-directed Mutagenesis Service Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Site-directed Mutagenesis Service Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Site-directed Mutagenesis Service Sales Value, 2019-2030
6.5.2 China Site-directed Mutagenesis Service Sales Value by Type (%), 2023 VS 2030
6.5.3 China Site-directed Mutagenesis Service Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Site-directed Mutagenesis Service Sales Value, 2019-2030
6.6.2 Japan Site-directed Mutagenesis Service Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Site-directed Mutagenesis Service Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Site-directed Mutagenesis Service Sales Value, 2019-2030
6.7.2 South Korea Site-directed Mutagenesis Service Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Site-directed Mutagenesis Service Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Site-directed Mutagenesis Service Sales Value, 2019-2030
6.8.2 Southeast Asia Site-directed Mutagenesis Service Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Site-directed Mutagenesis Service Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Site-directed Mutagenesis Service Sales Value, 2019-2030
6.9.2 India Site-directed Mutagenesis Service Sales Value by Type (%), 2023 VS 2030
6.9.3 India Site-directed Mutagenesis Service Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 GenScript
7.1.1 GenScript Profile
7.1.2 GenScript Main Business
7.1.3 GenScript Site-directed Mutagenesis Service Products, Services and Solutions
7.1.4 GenScript Site-directed Mutagenesis Service Revenue (US$ Million) & (2019-2024)
7.1.5 GenScript Recent Developments
7.2 Eurofins
7.2.1 Eurofins Profile
7.2.2 Eurofins Main Business
7.2.3 Eurofins Site-directed Mutagenesis Service Products, Services and Solutions
7.2.4 Eurofins Site-directed Mutagenesis Service Revenue (US$ Million) & (2019-2024)
7.2.5 Eurofins Recent Developments
7.3 Applied Biological Materials
7.3.1 Applied Biological Materials Profile
7.3.2 Applied Biological Materials Main Business
7.3.3 Applied Biological Materials Site-directed Mutagenesis Service Products, Services and Solutions
7.3.4 Applied Biological Materials Site-directed Mutagenesis Service Revenue (US$ Million) & (2019-2024)
7.3.5 Azenta Life Sciences Recent Developments
7.4 Azenta Life Sciences
7.4.1 Azenta Life Sciences Profile
7.4.2 Azenta Life Sciences Main Business
7.4.3 Azenta Life Sciences Site-directed Mutagenesis Service Products, Services and Solutions
7.4.4 Azenta Life Sciences Site-directed Mutagenesis Service Revenue (US$ Million) & (2019-2024)
7.4.5 Azenta Life Sciences Recent Developments
7.5 Thermo Fisher Scientific
7.5.1 Thermo Fisher Scientific Profile
7.5.2 Thermo Fisher Scientific Main Business
7.5.3 Thermo Fisher Scientific Site-directed Mutagenesis Service Products, Services and Solutions
7.5.4 Thermo Fisher Scientific Site-directed Mutagenesis Service Revenue (US$ Million) & (2019-2024)
7.5.5 Thermo Fisher Scientific Recent Developments
7.6 Bon Opus Biosciences
7.6.1 Bon Opus Biosciences Profile
7.6.2 Bon Opus Biosciences Main Business
7.6.3 Bon Opus Biosciences Site-directed Mutagenesis Service Products, Services and Solutions
7.6.4 Bon Opus Biosciences Site-directed Mutagenesis Service Revenue (US$ Million) & (2019-2024)
7.6.5 Bon Opus Biosciences Recent Developments
7.7 Charles Rive
7.7.1 Charles Rive Profile
7.7.2 Charles Rive Main Business
7.7.3 Charles Rive Site-directed Mutagenesis Service Products, Services and Solutions
7.7.4 Charles Rive Site-directed Mutagenesis Service Revenue (US$ Million) & (2019-2024)
7.7.5 Charles Rive Recent Developments
7.8 Creative Biogene
7.8.1 Creative Biogene Profile
7.8.2 Creative Biogene Main Business
7.8.3 Creative Biogene Site-directed Mutagenesis Service Products, Services and Solutions
7.8.4 Creative Biogene Site-directed Mutagenesis Service Revenue (US$ Million) & (2019-2024)
7.8.5 Creative Biogene Recent Developments
7.9 Synbio Technologies
7.9.1 Synbio Technologies Profile
7.9.2 Synbio Technologies Main Business
7.9.3 Synbio Technologies Site-directed Mutagenesis Service Products, Services and Solutions
7.9.4 Synbio Technologies Site-directed Mutagenesis Service Revenue (US$ Million) & (2019-2024)
7.9.5 Synbio Technologies Recent Developments
7.10 Creative Biolabs
7.10.1 Creative Biolabs Profile
7.10.2 Creative Biolabs Main Business
7.10.3 Creative Biolabs Site-directed Mutagenesis Service Products, Services and Solutions
7.10.4 Creative Biolabs Site-directed Mutagenesis Service Revenue (US$ Million) & (2019-2024)
7.10.5 Creative Biolabs Recent Developments
7.11 NovoPro
7.11.1 NovoPro Profile
7.11.2 NovoPro Main Business
7.11.3 NovoPro Site-directed Mutagenesis Service Products, Services and Solutions
7.11.4 NovoPro Site-directed Mutagenesis Service Revenue (US$ Million) & (2019-2024)
7.11.5 NovoPro Recent Developments
7.12 Bionexus
7.12.1 Bionexus Profile
7.12.2 Bionexus Main Business
7.12.3 Bionexus Site-directed Mutagenesis Service Products, Services and Solutions
7.12.4 Bionexus Site-directed Mutagenesis Service Revenue (US$ Million) & (2019-2024)
7.12.5 Bionexus Recent Developments
7.13 Biotech Desk
7.13.1 Biotech Desk Profile
7.13.2 Biotech Desk Main Business
7.13.3 Biotech Desk Site-directed Mutagenesis Service Products, Services and Solutions
7.13.4 Biotech Desk Site-directed Mutagenesis Service Revenue (US$ Million) & (2019-2024)
7.13.5 Biotech Desk Recent Developments
7.14 NorClone
7.14.1 NorClone Profile
7.14.2 NorClone Main Business
7.14.3 NorClone Site-directed Mutagenesis Service Products, Services and Solutions
7.14.4 NorClone Site-directed Mutagenesis Service Revenue (US$ Million) & (2019-2024)
7.14.5 NorClone Recent Developments
7.15 Eton Bioscience
7.15.1 Eton Bioscience Profile
7.15.2 Eton Bioscience Main Business
7.15.3 Eton Bioscience Site-directed Mutagenesis Service Products, Services and Solutions
7.15.4 Eton Bioscience Site-directed Mutagenesis Service Revenue (US$ Million) & (2019-2024)
7.15.5 Eton Bioscience Recent Developments
7.16 Syd Labs
7.16.1 Syd Labs Profile
7.16.2 Syd Labs Main Business
7.16.3 Syd Labs Site-directed Mutagenesis Service Products, Services and Solutions
7.16.4 Syd Labs Site-directed Mutagenesis Service Revenue (US$ Million) & (2019-2024)
7.16.5 Syd Labs Recent Developments
7.17 Genosphere Biotechnologies
7.17.1 Genosphere Biotechnologies Profile
7.17.2 Genosphere Biotechnologies Main Business
7.17.3 Genosphere Biotechnologies Site-directed Mutagenesis Service Products, Services and Solutions
7.17.4 Genosphere Biotechnologies Site-directed Mutagenesis Service Revenue (US$ Million) & (2019-2024)
7.17.5 Genosphere Biotechnologies Recent Developments
7.18 WZ Biosciences
7.18.1 WZ Biosciences Profile
7.18.2 WZ Biosciences Main Business
7.18.3 WZ Biosciences Site-directed Mutagenesis Service Products, Services and Solutions
7.18.4 WZ Biosciences Site-directed Mutagenesis Service Revenue (US$ Million) & (2019-2024)
7.18.5 WZ Biosciences Recent Developments
7.19 FulenGen
7.19.1 FulenGen Profile
7.19.2 FulenGen Main Business
7.19.3 FulenGen Site-directed Mutagenesis Service Products, Services and Solutions
7.19.4 FulenGen Site-directed Mutagenesis Service Revenue (US$ Million) & (2019-2024)
7.19.5 FulenGen Recent Developments
7.20 GENEWIZ
7.20.1 GENEWIZ Profile
7.20.2 GENEWIZ Main Business
7.20.3 GENEWIZ Site-directed Mutagenesis Service Products, Services and Solutions
7.20.4 GENEWIZ Site-directed Mutagenesis Service Revenue (US$ Million) & (2019-2024)
7.20.5 GENEWIZ Recent Developments
7.21 iGene Biotechnology
7.21.1 iGene Biotechnology Profile
7.21.2 iGene Biotechnology Main Business
7.21.3 iGene Biotechnology Site-directed Mutagenesis Service Products, Services and Solutions
7.21.4 iGene Biotechnology Site-directed Mutagenesis Service Revenue (US$ Million) & (2019-2024)
7.21.5 iGene Biotechnology Recent Developments
7.22 Tsingke
7.22.1 Tsingke Profile
7.22.2 Tsingke Main Business
7.22.3 Tsingke Site-directed Mutagenesis Service Products, Services and Solutions
7.22.4 Tsingke Site-directed Mutagenesis Service Revenue (US$ Million) & (2019-2024)
7.22.5 Tsingke Recent Developments
7.23 AtaGenix
7.23.1 AtaGenix Profile
7.23.2 AtaGenix Main Business
7.23.3 AtaGenix Site-directed Mutagenesis Service Products, Services and Solutions
7.23.4 AtaGenix Site-directed Mutagenesis Service Revenue (US$ Million) & (2019-2024)
7.23.5 AtaGenix Recent Developments
7.24 Zoonbio Biotechnology
7.24.1 Zoonbio Biotechnology Profile
7.24.2 Zoonbio Biotechnology Main Business
7.24.3 Zoonbio Biotechnology Site-directed Mutagenesis Service Products, Services and Solutions
7.24.4 Zoonbio Biotechnology Site-directed Mutagenesis Service Revenue (US$ Million) & (2019-2024)
7.24.5 Zoonbio Biotechnology Recent Developments
8 Industry Chain Analysis
8.1 Site-directed Mutagenesis Service Industrial Chain
8.2 Site-directed Mutagenesis Service Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Site-directed Mutagenesis Service Sales Model
8.5.2 Sales Channel
8.5.3 Site-directed Mutagenesis Service Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer

Companies Mentioned:

GenScript
Eurofins
Applied Biological Materials
Azenta Life Sciences
Thermo Fisher Scientific
Bon Opus Biosciences
Charles Rive
Creative Biogene
Synbio Technologies
Creative Biolabs
NovoPro
Bionexus
Biotech Desk
NorClone
Eton Bioscience
Syd Labs
Genosphere Biotechnologies
WZ Biosciences
FulenGen
GENEWIZ
iGene Biotechnology
Tsingke
AtaGenix
Zoonbio Biotechnology

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.